ADDITION OF NEW YORK-BASED FIRM COMPLEMENTS AND STRATEGICALLY EXPANDS PRECISION’S EXISTING GLOBAL MARKET ACCESS EXPERTISE AND CAPABILITIES

New York, NY – Tuesday, January 30, 2018 – Precision Value & Health today announced it is acquiring Insight Strategy Advisors (ISA), a New York-based leading market access consultancy supporting value demonstration, pricing, reimbursement, and distribution for biopharmaceutical companies. ISA will become part of Precision Xtract, the global market access consultancy within Precision Value & Health.

(more…)

Jeremy Schafer, SVP, Director of Precision’s Payer Access Solutions, offers advice to healthcare executives on helping patients get access to crucial new cancer drugs. (more…)

Jeremy Schafer, director of Precision’s Payer Access Solutions, offers insights into combating the risk and exposures of gene therapy. (more…)

In its weekly digest, GenomeWeb reports on Precision for Medicine’s expansion of biomarker data management and translational informatics services. (more…)

Jeremy Schafer, director of Precision’s Payer Access Solutions, contributes his perspectives on drug pricing in a PharmaVOICE feature article. (more…)

ADDITION OF GENEVA-BASED TEAM COMPLEMENTS U.S. EXPERTS;
QuartzBio? RELEASE ACCELERATES BIOMARKER DATA MANAGEMENT
AND TRANSLATIONAL INFORMATICS CAPABILITIES

Bethesda, MD and Geneva, Switzerland – January 9, 2018 – Precision for Medicine, part of Precision Medicine Group, today announced it is expanding its biomarker data management and translational informatics services into Europe. The addition of a Geneva, Switzerland–based team of experts complements Precision’s US offerings to provide clients with truly global translational research services. The Geneva team also gives Precision another European operational base, continuing Precision’s active international expansion.

(more…)

BERKSHIRE PARTNERS AND TPG GROWTH CO-LEAD $275 MILLION INVESTMENT AS THE COMPANY POSITIONS FOR THE NEXT PHASE OF GROWTH

BETHESDA, MD — December 19, 2017 — Precision Medicine Group (PMG) announced today that it has reached an agreement for a $275 million investment that positions the company for the next phase of growth. (more…)

Precision Xtract is proud to be named one of the year’s most innovative developments by industry insider PM360. (more…)

A new Precision Health Economics-authored study on the societal value of CAR-T therapy is generating a significant level of interest within the scientific community. (more…)